Spontaneous epileptiform discharges in a mouse model of Alzheimer's disease are suppressed by antiepileptic drugs that block sodium channels
暂无分享,去创建一个
H. Tanila | A. Pitkänen | K. Gurevicius | J. Nissinen | T. Bolkvadze | Nino Kutchiashvili | Sofya Ziyatdinova
[1] D. Bredesen,et al. Abnormal neuronal networks and seizure susceptibility in mice overexpressing the APP intracellular domain , 2011, Neurobiology of Aging.
[2] Steven Petrou,et al. Axon initial segment dysfunction in epilepsy , 2010, The Journal of physiology.
[3] J. Gotman,et al. Antiepileptic drugs abolish ictal but not interictal epileptiform discharges in vitro , 2010, Epilepsia.
[4] Long-chuan Yu,et al. Intracellular amyloid induces impairments on electrophysiological properties of cultured human neurons , 2009, Neuroscience Letters.
[5] Hyunmi Choi,et al. Seizures in Alzheimer disease: who, when, and how common? , 2009, Archives of neurology.
[6] L. Mucke,et al. Epilepsy and cognitive impairments in Alzheimer disease. , 2009, Archives of neurology.
[7] Sylvain Rheims,et al. Amyloid β-Induced Neuronal Hyperexcitability Triggers Progressive Epilepsy , 2009, The Journal of Neuroscience.
[8] C. Alzheimer,et al. Non-proteolytic effect of β-site APP-cleaving enzyme 1 (BACE1) on sodium channel function , 2009, Neurobiology of Disease.
[9] R. Petersen,et al. Recurrent seizures in patients with dementia: Frequency, seizure types, and treatment outcome , 2009, Epilepsy & Behavior.
[10] N. Belyaev,et al. Neprilysin gene expression requires binding of the amyloid precursor protein intracellular domain to its promoter: implications for Alzheimer disease , 2009, EMBO reports.
[11] H. Qing,et al. Valproic acid inhibits Aβ production, neuritic plaque formation, and behavioral deficits in Alzheimer's disease mouse models , 2008, The Journal of Experimental Medicine.
[12] C. Peers,et al. Modulation of ‘A’-type K+ current by rodent and human forms of amyloid &bgr; protein , 2008, Neuroreport.
[13] Béla Clemens,et al. Valproate decreases EEG synchronization in a use-dependent manner in idiopathic generalized epilepsy , 2008, Seizure.
[14] A. Draguhn,et al. Amyloid β Oligomers (Aβ1–42 Globulomer) Suppress Spontaneous Synaptic Activity by Inhibition of P/Q-Type Calcium Currents , 2008, The Journal of Neuroscience.
[15] Anatol C. Kreitzer,et al. Aberrant Excitatory Neuronal Activity and Compensatory Remodeling of Inhibitory Hippocampal Circuits in Mouse Models of Alzheimer's Disease , 2007, Neuron.
[16] A. Davoli,et al. Influence of levetiracetam on the anticonvulsant efficacy of conventional antiepileptic drugs against audiogenic seizures in DBA/2 mice , 2007, Epilepsy Research.
[17] V. Lee,et al. BACE1 regulates voltage-gated sodium channels and neuronal activity , 2007, Nature Cell Biology.
[18] A. Pitkänen,et al. Effect of antiepileptic drugs on spontaneous seizures in epileptic rats , 2007, Epilepsy Research.
[19] Massimo Mantegazza,et al. Reduced sodium current in GABAergic interneurons in a mouse model of severe myoclonic epilepsy in infancy , 2006, Nature Neuroscience.
[20] D. Lozsádi,et al. Prevalence and Causes of Seizures at the Time of Diagnosis of Probable Alzheimer’s Disease , 2006, Dementia and Geriatric Cognitive Disorders.
[21] Yaakov Stern,et al. Incidence and Predictors of Seizures in Patients with Alzheimer's Disease , 2006, Epilepsia.
[22] N. Burnashev,et al. Non‐fibrillar β‐amyloid abates spike‐timing‐dependent synaptic potentiation at excitatory synapses in layer 2/3 of the neocortex by targeting postsynaptic AMPA receptors , 2006, The European journal of neuroscience.
[23] M. Doran,et al. Clinical phenotypic heterogeneity of Alzheimer's disease associated with mutations of the presenilin–1 gene , 2006, Journal of Neurology.
[24] P. Patsalos,et al. Pharmacodynamic and Pharmacokinetic Characterization of Interactions between Levetiracetam and Numerous Antiepileptic Drugs in the Mouse Maximal Electroshock Seizure Model: An Isobolographic Analysis , 2006, Epilepsia.
[25] Chu Chen,et al. β-Amyloid increases dendritic Ca2+ influx by inhibiting the A-type K+ current in hippocampal CA1 pyramidal neurons , 2005 .
[26] B. Carey,et al. Presenilin/γ-Secretase-mediated Cleavage of the Voltage-gated Sodium Channel β2-Subunit Regulates Cell Adhesion and Migration* , 2005, Journal of Biological Chemistry.
[27] R. Twyman,et al. Correlation analysis between anticonvulsant ED50 values of antiepileptic drugs in mice and rats and their therapeutic doses and plasma levels , 2004, Epilepsy & Behavior.
[28] F. Liu,et al. Lithium, a common drug for bipolar disorder treatment, regulates amyloid-beta precursor protein processing. , 2004, Biochemistry.
[29] N. Belluardo,et al. Influence of carbenoxolone on the anticonvulsant efficacy of conventional antiepileptic drugs against audiogenic seizures in DBA/2 mice. , 2004, European journal of pharmacology.
[30] Joanna L. Jankowsky,et al. Mutant presenilins specifically elevate the levels of the 42 residue β-amyloid peptide in vivo: evidence for augmentation of a 42-specific γ secretase , 2004 .
[31] Daniel Storzbach,et al. Assessment of CNS Effects of Antiepileptic Drugs by Using Quantitative EEG Measures , 2003, Epilepsia.
[32] Nick C Fox,et al. Epilepsy presenting as AD: Neuroimaging, electroclinical features, and response to treatment , 2002, Neurology.
[33] T. Halonen,et al. Effect of lamotrigine treatment on status epilepticus-induced neuronal damage and memory impairment in rat , 2001, Epilepsy Research.
[34] J. Qiao,et al. Suppression of large conductance Ca2+-activated K+ channels by amyloid beta-protein fragment 31-35 in membrane patches excised from hippocampal neurons. , 2001, Sheng li xue bao : [Acta physiologica Sinica].
[35] C. Armon,et al. Alzheimer's disease underlies some cases of complex partial status epilepticus. , 2000, Journal of clinical neurophysiology : official publication of the American Electroencephalographic Society.
[36] U. Heinemann,et al. Effects of standard anticonvulsant drugs on different patterns of epileptiform discharges induced by 4-aminopyridine in combined entorhinal cortex–hippocampal slices , 2000, Brain Research.
[37] Asla Pitkänen,et al. A new model of chronic temporal lobe epilepsy induced by electrical stimulation of the amygdala in rat , 2000, Epilepsy Research.
[38] Chen-Hsiung Yeh,et al. Enhancement of Outward Potassium Current May Participate in β-Amyloid Peptide-Induced Cortical Neuronal Death , 1998, Neurobiology of Disease.
[39] M. Mattson,et al. Activation of K+ channels and suppression of neuronal activity by secreted β-amyloid-precursor protein , 1996, Nature.
[40] M. Mendez,et al. Seizures in Alzheimer's Disease: Clinicopathologic Study , 1994, Journal of geriatric psychiatry and neurology.
[41] M. Avoli,et al. Effects of antiepileptic drugs on 4-aminopyridine-induced epileptiform activity in young and adult rat hippocampus , 1992, Epilepsy Research.
[42] J. Morris,et al. Advanced Alzheimer's disease is a risk factor for late-onset seizures. , 1990, Archives of neurology.
[43] W. Hauser,et al. Seizures and myoclonus in patients with Alzheimer's disease , 1986, Neurology.
[44] R. Racine,et al. Modification of seizure activity by electrical stimulation. II. Motor seizure. , 1972, Electroencephalography and clinical neurophysiology.
[45] J. Malter,et al. Seizure susceptibility and mortality in mice that over-express amyloid precursor protein. , 2008, International journal of clinical and experimental pathology.
[46] E. Sinforiani,et al. Memory disturbances and temporal lobe epilepsy simulating Alzheimer's disease: a case report. , 2003, Functional neurology.
[47] S. M. Sumi,et al. Myoclonus, Seizures, and Paratonia in Alzheimer Disease , 1990, Alzheimer disease and associated disorders.